Previous Article | Next Article 
Journal of Clinical Microbiology, January 2002, p. 128-132, Vol. 40, No. 1
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.1.128-132.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Detection of Chlamydia trachomatis by Isothermal Ramification Amplification Method: a Feasibility Study
Wandi Zhang,1 Menashi Cohenford,2 Brian Lentrichia,2 Henry D. Isenberg,1 Elkin Simson,1 Hengjin Li,1 Jizu Yi,1 and David Y. Zhang1*
Department of Pathology, Mount Sinai School of Medicine, New York University, New York, New York 10029,1
Cytyc Corporation, Boxborough, Massachusetts 017192
Received 13 August 2001/
Returned for modification 24 September 2001/
Accepted 28 October 2001

ABSTRACT
Chlamydia trachomatis is the leading cause of sexually transmitted
disease in the United States. Effective screening for this agent
can facilitate prompt treatment and prevent its sequelae. The
recent introduction of liquid-based cytology has made possible
the simultaneous screening of cervical intraepithelial lesions
and detection of
C. trachomatis in a single collection vial.
In this study we determined whether cytological fluid could
support DNA-based amplification for the detection of
C. trachomatis.
Three methods were compared, including ramification amplification
(RAM), real-time PCR with molecular beacon, and Abbotts
ligase chain reaction (LCx). RAM is a novel, recently introduced,
isothermal DNA amplification technique that utilizes a circular
probe for target detection and achieves exponential amplification
through the mechanism of primer extension, strand displacement,
and ramification. Our results show that RAM can detect as few
as 10
C. trachomatis elementary bodies in less than 2 h, comparable
to results with real-time PCR. Thirty clinical specimens collected
in PreservCyt solution were tested by LCx, real-time PCR, and
RAM. Among 30 specimens, 15 were positive by PCR and LCx and
14 were positive by RAM. One specimen missed by RAM had an inadequate
amount of residual cellular material. Our results show that
nucleic acid amplification methods can serve to detect
C. trachomatis and presumably other sexually transmitted agents in cytological
fluid and that the RAM assay can be an alternative to PCR and
LCx because of its simplicity and isothermal amplification.

INTRODUCTION
Chlamydia trachomatis is one of the leading causes of sexually
transmitted diseases (STDs) in the Western world. An estimated
four million cases occur annually in the United States (
2,
10).
Since infection with this agent is often asymptomatic (
18,
19),
many infected individuals are not readily identified and go
untreated. Therefore, it is important to identify patients infected
with this organism not only to reduce transmission but also
to minimize the risk of more serious infections and their sequelae
(
17). Increasing awareness of the need to contain the spread
of chlamydia in the United States has led to recommendations
by clinicians and government agencies to adopt widespread screening
for this pathogen (
15,
20).
Until recently, the gold standard for identifying C. trachomatis has been the culture method. Although specific, this procedure is time consuming and laborious and is unfit for the routine screening of C. trachomatis in clinical specimens (6). With the advent of molecular testing, most laboratories have abandoned the culture method and instead have relied on the use of such sensitive and convenient techniques as PCR (4, 6), ligase chain reaction (4), strand displacement assay (4), and nucleic acid-based amplification (14). Our laboratory has recently invented a novel molecular technique, which we termed the ramification amplification method (RAM) (2123). The technique utilizes a circular probe (C-probe) for target detection and a capture probe for target isolation. One of the significant advantages of the technique is that there is no need for thermocycling to facilitate the amplification. Furthermore, the combination of magnetic isolation and isothermal DNA amplification makes this assay amenable for clinical diagnosis.
The implementation of fluid-based collection of endocervical scrapes into PreservCyt (Cytyc Corporation, Boxborough, Mass.) for Pap testing facilitates screening of female populations by cytological examination. It follows that a sensitive DNA amplification method could also be used to detect STDs, including human papillomavirus (F. Yarkin, S. Chauvin, N. Konomi, W. Wang, R. Mo, G. Bauchman, A. Diaz, D. Burstein, A. Szporn, E. Hauptman, and D. Y. Zhang, submitted for publication) and C. trachomatis (9) from the same PreservCyt collection vial. The aim of the study was to determine the feasibility of detecting C. trachomatis DNA in a gynecological sample collected in PreservCyt solution by RAM technology and to compare results of RAM assay with those of Abbotts ligase chain reaction method (LCx) and with a real-time PCR method.

MATERIALS AND METHODS
Sample preparation.
A group of 30 residual endocervical specimens in PreservCyt
were selected for this study. Of this group, 15 specimens tested
positive and 15 tested negative for
C. trachomatis DNA by LCx
and real-time PCR. For the RAM assay, 1 ml of each specimen
was centrifuged at 14,000 rpm for 15 min in an Eppendorf centrifuge
5417C. The sediment was lysed by incubation at 60°C for
60 min in 50 to 100 µl of a lysis buffer containing 400
mM Tris-HCl buffer (pH 7.5), 5 M guanidium thiocyanate (GTC)
(Sigma, St. Louis, Mo.), 0.5% bovine serum albumin (Sigma),
80 mM EDTA, and 0.5% sodium-
N-lauroylsarcosine (Sigma). The
lysed specimens were stored at -20°C until use.
For real-time PCR testing, DNA was extracted with 1% ethylene glycol monomethyl ether in 2 mM borate buffer (pH 9.5). Briefly, 1 ml of PreservCyt sample was centrifuged at 13,000 rpm for 10 min, the supernatant was decanted, and the cell pellet was then resuspended in a 200-µl aliquot of the extraction fluid. The cell pellet was vortexed, and the suspension was then heated at 98°C for 10 min. The solution containing the extracted DNA was then brought to room temperature and tested by PCR.
RAM assay.
The RAM assay consists of steps including hybridization of the C-probe and capture probe to a target, capture of the hybrid onto magnetic beads, washing of the beads to remove unbound probes and cellular components, ligation of the 3' and 5' ends to form a closed C-probe, and amplification by primer extension, strand displacement, and ramification (Fig. 1) (23). Hybridization of the C-probe, capture probe, and target was carried out in an 80-µl reaction mixture containing 2 M GTC, 0.5% bovine serum albumin (Sigma), 80 mM EDTA, 400 mM Tris-HCl (pH 7.5), 0.5% sodium-N-lauroylsarcosine (Sigma), 50 nM phosphorylated C-probe, 2 µM capture probe (Table 1), and 5 to 15 µl of lysed specimens or DNA target. The reaction was incubated at 55°C for 2 h to allow hybrid formation. Three microliters of streptavidin-coated magnetic beads (10 mg/ml; Dynal, Lake Success, N.Y.), 80 µl of 10 mM Tris-HCl (pH 7.5) with 1 mM EDTA, and 2 M NaCl were added to the hybridization mixture and incubated at room temperature for 20 min to allow the hybrids to be captured on the beads through the binding of biotin of the capture probe with streptavidin coated on the bead surface. The beads with bound complex were then washed twice with 400 µl of TE buffer (10 mM Tris-HCl [pH 8] and 1 mM EDTA) at room temperature to remove unhybridized C-probes and other cellular components. Twenty microliters of ligase mixture containing 20 mM Tris-HCl (pH 7.6), 25 mM potassium acetate, 10 mM magnesium acetate, 10 mM dithiothreitol, 1 mM nicotiamide adenosine dinucleotides 0.1% Triton X-100, and 12 U of Taq DNA ligase (New England Biolabs, Beverly, Mass.) were added to the bead pellet and incubated at 60°C for 20 min. Ligation of the 3' and 5' ends hybridized to the target allowed the formation of a closed circle that locked on the target. After ligation, the RAM reaction solution was aspirated and the beads were suspended in 50 µl of RAM reaction smixture containing 300 µM deoxynucleoside triphosphate (USB Biochemicals), 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton X-100, 1.2 µM concentration of forward and reverse primers, 6.4 U of Bst DNA polymerase large fragment (New England Biolabs), 1 µg of T4 gene 32 protein (USB Biochemicals), and 6% dimethyl sulfoxide. This mixture was incubated at 63°C for 1 h, followed by heating at 95°C for 5 min to inactivate Bst DNA polymerase. Fifteen microliters of RAM reaction products were transferred to 5 µl of 50 mM Tris-HCl buffer (pH 7) containing 15 U of EcoRI (Boehringer Mannheim), 100 mM MgCl2, 1 mM dithiothreitol and incubated at 37°C for 3 h. The digested products were analyzed on a 2% agarose gel.
Real-time PCR detection of C. trachomatis DNA.
The PCR amplification of
C. trachomatis DNA was performed with
a primer set (Table
1) that is specific to the KL1 and KL2 region
of the
C. trachomatis plasmid (
12,
13). This set of primers
amplified a 79-bp sequence. Amplification product was detected
with a molecular beacon of 42 nucleotides in length (Table
1).
Real-time PCR amplification and detection were achieved using
the LightCycler PCR System (Roche Molecular Biochemicals, Indianapolis,
Ind.) as described previously (
12). The reaction was carried
out in a 20-µl mixture containing 50 mM KCl, 10 mM Tris-HCl
buffer (pH 8.3), 8.33 mM MgCl
2, 200 µM of each deoxynucleoside
triphosphate, 0.75 M betaine, 1 µM concentrations of each
primer, 1 U of Platinum
Taq Polymerase (Perkin Elmer Cetus,
P.E. Roche Molecular System, Inc., Branchburg, N.J.), 50 nM
molecular beacon, and 4 µl of target DNA. Typical thermocycling
conditions included an initial denaturation step at 95°C
for 1 min followed by 45 cycles each consisting of a denaturation
step at 95°C for 5 s, primer and molecular beacon annealing
steps at 48°C (20 s) and 53°C (22 s), and an extension
step at 72°C (10 s).
LCx assay.
Abbotts LCx assay was performed according to the manufacturers instructions but on DNA that was extracted from cells that were pelleted from PreservCyt solution. Unless otherwise indicated, the DNA from the cells was extracted by Abbotts LCx urine protocol (manufacturers insert sheet, no. 3B21-24).

RESULTS
Analytical sensitivity of RAM assay.
The analytical sensitivity of the RAM assay was determined with
a synthetic
C. trachomatis DNA target (Table
1). The DNA was
diluted in 10-fold serials from 10
7 to 10
1 molecules and was
used for RAM assay. Our results show that the lowest number
of targets detected by this assay was 10 molecules (Fig.
2A),
and the reactions were confirmed by finding the correct products
(124 bp) in each lane after digestion with
EcoRI, establishing
the C-probe as their source. In the absence of target molecule,
no DNA was produced, proving the target-dependent amplification
of the C-probe. The assay sensitivity was further determined
using
C. trachomatis elementary bodies (EB) collected in Cytyc
PreservCyt solution. The
C. trachomatis EB were obtained from
infected McCoy cell culture and quantified by direct counts
after fluorescent antibody staining (
1). The
C. trachomatis EB were lysed in 5 M GTC, diluted to 250, 100, and 10 copies,
and used for the RAM assay. The results in Fig.
2B show that
the assay detected as few as 10 EB copies, comparable to the
sensitivity of real-time PCR (data not shown).
Detection of C. trachomatis in patient samples.
The samples were initially tested by real-time PCR and LCx for
C. trachomatis and then by the RAM assay. Of the 30 samples,
15 samples tested positive for
C. trachomatis DNA and 15 yielded
a negative
C. trachomatis DNA result by PCR and LCx (Table
2).
All samples positive by PCR were also positive by LCx, and all
that were negative by PCR were also negative by LCx. In the
case of PCR, the criterion used to determine the presence of
C. trachomatis DNA in the sample was a cycle that yielded a
linear increase in detectable fluorescence signal (threshold
cycle). In the case of LCx, the diagnostic status of the samples
was determined on the basis of the manufacturers recommended
sample/cutoff (S/CO) ratios.
Evaluation of the specimens by RAM revealed that of the 15
C. trachomatis-positive samples, only 14 specimens tested positive
for
C. trachomatis DNA (Table
2). The one specimen (no. 11)
testing negative by RAM that was positive by PCR and LCx contained
negligible amounts of cellular material as determined by inspection.
Of the remaining 15 specimens that tested negative by PCR and
LCx, all yielded a negative RAM result, confirming the high
specificity of the RAM assay for
C. trachomatis DNA. Furthermore,
RAM accurately detected a wide range of
C. trachomatis DNA in
clinical samples, as indicated by PCR cycles (24 to 44 cycles)
and S/CO ratio (4.39 to 1.85). For example, one of the samples
(no. 20) had a low copy number of
C. trachomatis DNA, since
it required 44 cycles to become positive by PCR and had a low
S/CO ratio (1.85) by LCx. Fig.
2C shows the agarose gel of the
RAM products that were generated from PreservCyt samples 1 through
10.

DISCUSSION
We describe a novel strategy that combines magnetic isolation
of target DNA/C-probe hybrids, target-specific ligation of C-probe,
and isothermal amplification of the ligated C-probe. One-step
isolation of
C. trachomatis DNA with paramagnetic beads offers
several advantages. First, dissolution of residual cellular
material in 5 M GTC lyses cells, denatures proteins, inactivates
nucleases, and relaxes DNA helices. Subsequent reduction of
the GTC concentration to 2 M promotes the rapid formation of
hybrids between target DNA and C-probes. Second, the capture
of DNA-C-probe hybrids on paramagnetic beads allows extensive
washing to remove all other components in the specimen that
may inhibit ligation and PCR (
7). In addition, removal of nontarget
nucleic acids present in the specimen and unbound C-probes significantly
reduces the probability of false-positive signals and background.
Third, the use of magnetic isolation eliminates complicated,
laborious manual DNA extraction procedures and enables the high-throughput
processing of a large number of specimens in a clinical laboratory
setting (
7).
The circular probe has several unique features (22, 23). First, the formation of a closed C-probe requires target-specific ligation of the C-probe, therefore significantly increasing assay specificity. The 5' end of the C-probe must align perfectly with the 3' end on a target DNA in order for ligation to occur (7, 11). Furthermore, the stringent requirement of ligation makes detection of a single nucleotide polymorphism possible (11). Second, the C-probe can be amplified with a set of generic primers that bind to the loop region of the C-probe (Fig. 1) (7), making multiplex detection of different targets possible. It has been shown that because of the efficiency of different PCR primer pairs, multiplexing of PCR is sometimes difficult to perform (3, 16). In our case, different C-probes specific for different targets can be amplified with the same set of primers, eliminating competition among primers. This offers great advantages for the detection of most sexually transmitted agents (i.e., human papillomavirus, C. trachomatis, and Neisseria gonorrhoeae) in a single reaction from a single collection vial. Third, the circular probe allows a long single-stranded DNA (ssDNA) to form with up to thousands of repeats (21). This ssDNA can be further amplified by the ramification process as described previously. Since no temperature cycling is required, the reaction can be carried out in a simple water bath, obviating the use of an expensive thermocycler.
The liquid-based ThinPrep method of sample collection and slide preparation has significantly improved cytology diagnosis (8) and has allowed the use of PreservCyt specimens in addition to the Pap test, for the detection of such STD agents as C. trachomatis (12), N. gonorrhoeae (12), human papillomavirus (Yarkin et al., submitted), and herpes simplex virus (5). Our results with specimens that were stored in the methanol-based PreservCyt solution showed that under the conditions of testing, PreservCyt had no apparent inhibitory effect on PCR, ligase chain reaction, and RAM and that no components of PreservCyt interfered with the functionality of the molecular beacon that was used for the detection of amplified PCR products. Like PCR, the RAM assay also proved sensitive and detected as few as 10 copies of C. trachomatis DNA.
In summary, the RAM assay offers a viable alternative to PCR and LCx for the detection of C. trachomatis DNA from PreservCyt. With minor modifications, this assay can be used with molecular beacon technology for the real-time detection of C. trachomatis DNA and other STD agents in PreservCyt (data not shown). The high sensitivity and specificity of the RAM assay coupled with its ease of use thus encourages a further investigation of this technique.

FOOTNOTES
* Corresponding author. Mailing address: Molecular Pathology Laboratory, Mount Sinai School of Medicine, Box 1122, One Gustave Levy Place, New York, NY 10021. Phone: (212) 659-8173. Fax: (212) 427-2082. E-mail:
David.Zhang{at}Mountsinai.org.


REFERENCES
1 - An, Q., J. Liu, W. OBrien, G. Radcliffe, D. Buxton, S. Popoff, W. King, M. Vera-Garcia, L. Lu, J. Shah, J. Klingler, and D. M. Oliver. 1995. Comparison of characteristics of Q beta replicase-amplified assay with competitive PCR assay for Chlamydia trachomatis. J. Clin. Microbiol. 33:5863.[Abstract]
2 - Center for Disease Control. 1985. Chlamydia trachomatis infections: Policy guidelines for prevention and control. Morb. Mortal. Wkly. Rep. 34(Suppl.):5373.
3 - Cha, T. A., J. Kolberg, B. Irvine, M. Stempien, E. Beall, M. Yano, A. L. Choo, M. Houghton, G. Kuo, J. H. Han, and M. S. Urdea. 1991. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J. Clin. Microbiol. 29:25282534.[Abstract/Free Full Text]
4 - Dyck, E. V., M. Ieven, S. Pattyn, L. V. Damme, and M. Laga. 2001. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J. Clin. Microbiol. 39:17511756.[Abstract/Free Full Text]
5 - Fiel-Gan, M. D., C. F. Villamil, S. R. Mandavilli, M. E. Ludwig, and G. J. Tsongalis. 1999. Rapid detection of HSV from cytologic specimens collected into ThinPrep fixative. Acta Cytol. 43:10341038.[Medline]
6 - Hsuih, T., A. Guichon, A. Diaz, E. J. Bottone, R. Sperling, and D. Y. Zhang. 1995. Chlamydial infection in a high-risk population: comparison of Amplicor PCR and Gen-Probe PACE II for diagnosis. Adolesc. Pediatr. Gynecol. 8:7176.
7 - Hsuih, T. C. H., Y. N. Park, C. Zaretsky, F. Wu, S. Tyagi, F. R. Kramer, R. Sperling, and D. Y. Zhang. 1996. Novel, ligation-dependent PCR assay for detection of hepatitis C virus in serum. J. Clin. Microbiol. 34:501507.[Abstract]
8 - Hutchinson, M. L., D. J. Zahniser, M. E. Sherman, R. Herrero, M. Alfaro, M. C. Bratti, A. Hildesheim, A. T. Lorincz, M. D. Greenberg, J. Morales, and M. Schiffman. 1999. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 87:4855.[CrossRef][Medline]
9 - Inhorn, S. L., P. J. Wand, T. C. Wright, K. D. Hatch, J. Hallum, and B. B. Lentrichia. 2001. Chlamydia trachomatis and Pap testing from a single, fluid-based sample. J. Reprod. Med. 46:155162.
10 - Judson, F. N. 1985. Assessing the number of genital chlamydial infections in the United States. J. Reprod. Med. 30:269272.[Medline]
11 - Landegren, U., R. Kaiser, J. Sanders, and L. Hood. 1988. A ligase-mediated gene detection technique. Science 241:10771080.[Abstract/Free Full Text]
12 - Lentrichia, B. B., M. A. Cohenford, S. Hecht, E. Coffman, B. DZuira, and P. Thomas. 2001. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from liquid-based PAP collection using a novel extraction method and rapid thermal cycling with real-time detection by molecular beacons, p.6773. In International Proceedings Sexually Transmitted Infections. Monduzzi Editore, Berlin, Germany.
13 - Mahony, J. B., K. E. Luinstra, M. Tyndall, J. W. Sellors, J. Krepel, and M. Chernesky. 1995. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens. J. Clin. Microbiol. 33:30493053.[Abstract]
14 - Mahony, J. B., X. Song, S. Chong, M. Faught, T. Salonga, and J. Kapala. 2001. Evaluation of the NucliSens Basic Kit for detection of Chlamydia trachmatis and Neisseria gonorrhoeae in genital tract specimens using nucleic acid sequence-based amplification of 16S rRNA. J. Clin. Microbiol. 39:14291435.[Abstract/Free Full Text]
15 - Mangione-Smith, R., J. OLeary, and E. A. McGlymm. 1999. Health and cost-benefits of chlamydia screening in young women. Sex. Transm. Dis. 26:309316.[Medline]
16 - Okamoto, M., M. Baba, E. Kodama, K. Sekine, T. Takagi, R. Kasukawa, and S. Shigeta. 1993. Detection of hepatitis C virus genome in human serum by multi-targeted polymerase chain reaction. J. Med. Virol. 41:610.[Medline]
17 - Scholes, D., A. Stergachis, F. Heidrich, H. Andrilla, K. Holmes, and W. Stamm. 1996. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N. Engl. J. Med. 334:13621366.[Abstract/Free Full Text]
18 - Shafer, M. A., V. Prager, J. Schalwitz, E. Vaughan, B. Moscicki, R. Brown, C. Wibbelsman, and J. Schachter. 1987. Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J. Infect. Dis. 156:223224.[Medline]
19 - Smith, J. W., R. E. Rogers, B. P. Katz, J. F. Brickler, P. L. Lineback, B. V. D. Pol, and R. B. Jones. 1987. Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J. Clin. Microbiol. 25:868872.[Abstract/Free Full Text]
20 - Stamm, W. E., M. E. Guinan, C. Johnson, T. Starcher, K. K. Holmes, and McCormack. 1984. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N. Engl. J. Med. 310:545549.[Abstract]
21 - Zhang, D. Y., M. Brandwein, T. Hsuih, and H. B. Li. 2001. Ramification amplification: a novel isothermal DNA amplification method. Mol. Diagn. 6:141150.[CrossRef][Medline]
22 - Zhang, D. Y., M. Brandwein, T. C. H. Hsuih, and H. Li. 1998. Amplification of target-specific, ligation-dependent circular probe. Gene 211:277285.[CrossRef][Medline]
23 - Zhang, D. Y., W. Zhang, X. Li, and Y. Konomi. 2001. Detection of rare DNA targets by isothermal ramification amplification. Gene 247:209216.
Journal of Clinical Microbiology, January 2002, p. 128-132, Vol. 40, No. 1
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.1.128-132.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sevestre, H., Mention, J., Lefebvre, J.-F., Eb, F., Hamdad, F.
(2009). Assessment of Chlamydia trachomatis infection by Cobas Amplicor PCR and in-house LightCycler assays using PreservCyt and 2-SP media in voluntary legal abortions. J Med Microbiol
58: 59-64
[Abstract]
[Full Text]
-
Li, F., Zhao, C., Zhang, W., Cui, S., Meng, J., Wu, J., Zhang, D. Y.
(2005). Use of Ramification Amplification Assay for Detection of Escherichia coli O157:H7 and Other E. coli Shiga Toxin-Producing Strains. J. Clin. Microbiol.
43: 6086-6090
[Abstract]
[Full Text]
-
Vinayagamoorthy, T., Mulatz, K., Hodkinson, R.
(2003). Nucleotide Sequence-Based Multitarget Identification. J. Clin. Microbiol.
41: 3284-3292
[Abstract]
[Full Text]
-
Koumans, E. H., Black, C. M., Markowitz, L. E., Unger, ElizabethR., Pierce, A., Sawyer, M. K., Papp, J. R.
(2003). Comparison of Methods for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Using Commercially Available Nucleic Acid Amplification Tests and a Liquid Pap Smear Medium. J. Clin. Microbiol.
41: 1507-1511
[Abstract]
[Full Text]